Sen. Mike Braun (R-IN)(Francis Chung/POLITICO via AP Images)

Law­mak­ers push for faster, con­di­tion­al FDA ap­proval path­way for rare dis­ease drugs

As the FDA tight­ens its fo­cus on rare dis­ease treat­ments and speed­ing their en­try to mar­ket, law­mak­ers on Capi­tol Hill are putting se­ri­ous stock in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.